Structure

Physi-Chem Properties

Molecular Weight:  464.26
Volume:  498.774
LogP:  5.231
LogD:  4.129
LogS:  -4.505
# Rotatable Bonds:  5
TPSA:  83.83
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.326
Synthetic Accessibility Score:  4.469
Fsp3:  0.517
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.259
MDCK Permeability:  2.2497968529933132e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.013
20% Bioavailability (F20%):  0.749
30% Bioavailability (F30%):  0.553

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.058
Plasma Protein Binding (PPB):  97.72771453857422%
Volume Distribution (VD):  0.528
Pgp-substrate:  1.1182186603546143%

ADMET: Metabolism

CYP1A2-inhibitor:  0.355
CYP1A2-substrate:  0.389
CYP2C19-inhibitor:  0.786
CYP2C19-substrate:  0.206
CYP2C9-inhibitor:  0.568
CYP2C9-substrate:  0.917
CYP2D6-inhibitor:  0.772
CYP2D6-substrate:  0.862
CYP3A4-inhibitor:  0.628
CYP3A4-substrate:  0.329

ADMET: Excretion

Clearance (CL):  18.751
Half-life (T1/2):  0.792

ADMET: Toxicity

hERG Blockers:  0.505
Human Hepatotoxicity (H-HT):  0.197
Drug-inuced Liver Injury (DILI):  0.079
AMES Toxicity:  0.067
Rat Oral Acute Toxicity:  0.731
Maximum Recommended Daily Dose:  0.892
Skin Sensitization:  0.954
Carcinogencity:  0.51
Eye Corrosion:  0.013
Eye Irritation:  0.309
Respiratory Toxicity:  0.95

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471152

Natural Product ID:  NPC471152
Common Name*:   16-O-Caffeoyl-11-Oxocassa-12,14-Diene
IUPAC Name:   2-[(4aS,4bS,8aS,10aR)-4b,8,8-trimethyl-1-methylidene-4-oxo-4a,5,6,7,8a,9,10,10a-octahydrophenanthren-2-yl]ethyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  NUXCVQJWVRCNMX-CYELNHJYSA-N
Standard InCHI:  InChI=1S/C29H36O5/c1-18-20(12-15-34-26(33)11-7-19-6-9-22(30)23(31)16-19)17-24(32)27-21(18)8-10-25-28(2,3)13-5-14-29(25,27)4/h6-7,9,11,16-17,21,25,27,30-31H,1,5,8,10,12-15H2,2-4H3/b11-7+/t21-,25-,27+,29-/m0/s1
SMILES:  CC1(CCCC2(C1CCC3C2C(=O)C=C(C3=C)CCOC(=O)C=CC4=CC(=C(C=C4)O)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2381685
PubChem CID:   71615304
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33322 caesalpinia volkensii Species Fabaceae Eukaryota stem bark n.a. n.a. PMID[23562058]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 16530.0 nM PMID[495864]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 11630.0 nM PMID[495864]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471152 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9485 High Similarity NPC477873
0.9485 High Similarity NPC469447
0.9348 High Similarity NPC53520
0.9254 High Similarity NPC43353
0.9143 High Similarity NPC8102
0.9143 High Similarity NPC66894
0.9077 High Similarity NPC137416
0.9058 High Similarity NPC27518
0.9058 High Similarity NPC304110
0.9051 High Similarity NPC182249
0.8986 High Similarity NPC473591
0.8986 High Similarity NPC271494
0.8986 High Similarity NPC155192
0.8971 High Similarity NPC173569
0.8971 High Similarity NPC477874
0.8958 High Similarity NPC118033
0.8958 High Similarity NPC473579
0.8958 High Similarity NPC475454
0.8958 High Similarity NPC475311
0.8958 High Similarity NPC473680
0.8905 High Similarity NPC249817
0.8897 High Similarity NPC475579
0.8897 High Similarity NPC473773
0.8865 High Similarity NPC25491
0.8841 High Similarity NPC216940
0.8841 High Similarity NPC475482
0.8841 High Similarity NPC22676
0.8841 High Similarity NPC198621
0.8824 High Similarity NPC476282
0.8806 High Similarity NPC30174
0.8794 High Similarity NPC235557
0.8786 High Similarity NPC470035
0.8786 High Similarity NPC473612
0.8777 High Similarity NPC132723
0.8777 High Similarity NPC76032
0.8732 High Similarity NPC26045
0.8723 High Similarity NPC35212
0.8712 High Similarity NPC265413
0.8712 High Similarity NPC10154
0.8707 High Similarity NPC105942
0.8707 High Similarity NPC205392
0.869 High Similarity NPC264229
0.869 High Similarity NPC46549
0.8686 High Similarity NPC18982
0.8686 High Similarity NPC475457
0.8686 High Similarity NPC475627
0.8686 High Similarity NPC475346
0.8676 High Similarity NPC243305
0.8671 High Similarity NPC307205
0.8671 High Similarity NPC271607
0.8671 High Similarity NPC280717
0.8662 High Similarity NPC184935
0.8662 High Similarity NPC252133
0.8662 High Similarity NPC310621
0.8652 High Similarity NPC472801
0.8652 High Similarity NPC172311
0.8643 High Similarity NPC234548
0.8643 High Similarity NPC248287
0.8623 High Similarity NPC194970
0.8611 High Similarity NPC75295
0.8611 High Similarity NPC258856
0.8592 High Similarity NPC472410
0.8582 High Similarity NPC471875
0.8571 High Similarity NPC474532
0.8542 High Similarity NPC235195
0.8542 High Similarity NPC19862
0.8529 High Similarity NPC470747
0.8529 High Similarity NPC86257
0.8521 High Similarity NPC29599
0.8511 High Similarity NPC469680
0.8511 High Similarity NPC469681
0.8511 High Similarity NPC471974
0.8511 High Similarity NPC116742
0.8511 High Similarity NPC139243
0.85 High Similarity NPC7464
0.85 High Similarity NPC476699
0.8489 Intermediate Similarity NPC471913
0.8462 Intermediate Similarity NPC203124
0.8451 Intermediate Similarity NPC470616
0.8451 Intermediate Similarity NPC470617
0.8433 Intermediate Similarity NPC15127
0.8433 Intermediate Similarity NPC288945
0.8425 Intermediate Similarity NPC472938
0.8425 Intermediate Similarity NPC472937
0.8425 Intermediate Similarity NPC273798
0.8425 Intermediate Similarity NPC472936
0.8414 Intermediate Similarity NPC8493
0.8414 Intermediate Similarity NPC144247
0.8414 Intermediate Similarity NPC469375
0.8414 Intermediate Similarity NPC294679
0.8414 Intermediate Similarity NPC145301
0.8411 Intermediate Similarity NPC471968
0.8409 Intermediate Similarity NPC470848
0.8409 Intermediate Similarity NPC470849
0.8403 Intermediate Similarity NPC469855
0.8403 Intermediate Similarity NPC471971
0.8403 Intermediate Similarity NPC471972
0.8403 Intermediate Similarity NPC30846
0.8397 Intermediate Similarity NPC42657
0.8397 Intermediate Similarity NPC263386
0.8397 Intermediate Similarity NPC141791
0.8394 Intermediate Similarity NPC131684
0.8392 Intermediate Similarity NPC78987
0.8392 Intermediate Similarity NPC82336
0.838 Intermediate Similarity NPC469857
0.838 Intermediate Similarity NPC23667
0.838 Intermediate Similarity NPC477849
0.838 Intermediate Similarity NPC46242
0.838 Intermediate Similarity NPC473779
0.838 Intermediate Similarity NPC473479
0.838 Intermediate Similarity NPC50615
0.838 Intermediate Similarity NPC289358
0.838 Intermediate Similarity NPC245760
0.838 Intermediate Similarity NPC91887
0.838 Intermediate Similarity NPC114333
0.838 Intermediate Similarity NPC157284
0.838 Intermediate Similarity NPC165191
0.838 Intermediate Similarity NPC28592
0.838 Intermediate Similarity NPC5014
0.838 Intermediate Similarity NPC149773
0.838 Intermediate Similarity NPC42384
0.838 Intermediate Similarity NPC51531
0.838 Intermediate Similarity NPC297797
0.8378 Intermediate Similarity NPC470619
0.8378 Intermediate Similarity NPC208785
0.8378 Intermediate Similarity NPC470618
0.8378 Intermediate Similarity NPC145527
0.8378 Intermediate Similarity NPC327962
0.8369 Intermediate Similarity NPC90431
0.8367 Intermediate Similarity NPC96930
0.8367 Intermediate Similarity NPC32017
0.8356 Intermediate Similarity NPC470038
0.8345 Intermediate Similarity NPC209085
0.8345 Intermediate Similarity NPC199936
0.8345 Intermediate Similarity NPC224884
0.8333 Intermediate Similarity NPC266084
0.8333 Intermediate Similarity NPC473544
0.8333 Intermediate Similarity NPC475145
0.8333 Intermediate Similarity NPC475162
0.8333 Intermediate Similarity NPC475216
0.8333 Intermediate Similarity NPC475595
0.8333 Intermediate Similarity NPC83663
0.8322 Intermediate Similarity NPC294330
0.8321 Intermediate Similarity NPC309434
0.8312 Intermediate Similarity NPC266365
0.8311 Intermediate Similarity NPC132810
0.8311 Intermediate Similarity NPC273358
0.8311 Intermediate Similarity NPC292206
0.8311 Intermediate Similarity NPC298647
0.831 Intermediate Similarity NPC277559
0.8299 Intermediate Similarity NPC474991
0.8299 Intermediate Similarity NPC471970
0.8298 Intermediate Similarity NPC472804
0.8298 Intermediate Similarity NPC103082
0.8298 Intermediate Similarity NPC252343
0.8288 Intermediate Similarity NPC469854
0.8288 Intermediate Similarity NPC469856
0.8286 Intermediate Similarity NPC168799
0.8286 Intermediate Similarity NPC155209
0.8284 Intermediate Similarity NPC478058
0.8278 Intermediate Similarity NPC305710
0.8278 Intermediate Similarity NPC62051
0.8276 Intermediate Similarity NPC229218
0.8276 Intermediate Similarity NPC141817
0.8276 Intermediate Similarity NPC176030
0.8276 Intermediate Similarity NPC285550
0.8276 Intermediate Similarity NPC192597
0.8276 Intermediate Similarity NPC169214
0.8273 Intermediate Similarity NPC198388
0.8267 Intermediate Similarity NPC221249
0.8267 Intermediate Similarity NPC124842
0.8264 Intermediate Similarity NPC473527
0.8264 Intermediate Similarity NPC38473
0.8255 Intermediate Similarity NPC261322
0.8255 Intermediate Similarity NPC142654
0.8255 Intermediate Similarity NPC472939
0.8255 Intermediate Similarity NPC237441
0.8243 Intermediate Similarity NPC325032
0.8243 Intermediate Similarity NPC477483
0.8239 Intermediate Similarity NPC120852
0.8239 Intermediate Similarity NPC470733
0.8235 Intermediate Similarity NPC197832
0.8231 Intermediate Similarity NPC84786
0.8231 Intermediate Similarity NPC474967
0.8227 Intermediate Similarity NPC68779
0.8227 Intermediate Similarity NPC176814
0.8227 Intermediate Similarity NPC11266
0.8227 Intermediate Similarity NPC471110
0.8227 Intermediate Similarity NPC4982
0.8227 Intermediate Similarity NPC106406
0.8227 Intermediate Similarity NPC5310
0.8227 Intermediate Similarity NPC300776
0.8219 Intermediate Similarity NPC183824
0.8214 Intermediate Similarity NPC165612
0.8214 Intermediate Similarity NPC61
0.8214 Intermediate Similarity NPC5419
0.8214 Intermediate Similarity NPC18074
0.8214 Intermediate Similarity NPC25581
0.8214 Intermediate Similarity NPC239302
0.8209 Intermediate Similarity NPC147654

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471152 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9701 High Similarity NPD8166 Discontinued
0.8273 Intermediate Similarity NPD6663 Approved
0.8248 Intermediate Similarity NPD5736 Approved
0.806 Intermediate Similarity NPD2932 Approved
0.806 Intermediate Similarity NPD3019 Approved
0.7848 Intermediate Similarity NPD8127 Discontinued
0.7815 Intermediate Similarity NPD6273 Approved
0.7785 Intermediate Similarity NPD6190 Approved
0.7778 Intermediate Similarity NPD7458 Discontinued
0.7762 Intermediate Similarity NPD8032 Phase 2
0.7755 Intermediate Similarity NPD7266 Discontinued
0.7727 Intermediate Similarity NPD7028 Phase 2
0.7718 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7718 Intermediate Similarity NPD7003 Approved
0.7718 Intermediate Similarity NPD4110 Phase 3
0.7698 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD3022 Approved
0.7634 Intermediate Similarity NPD3021 Approved
0.7622 Intermediate Similarity NPD7095 Approved
0.7609 Intermediate Similarity NPD3026 Approved
0.7609 Intermediate Similarity NPD3023 Approved
0.76 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD4628 Phase 3
0.7591 Intermediate Similarity NPD3024 Approved
0.7591 Intermediate Similarity NPD3025 Approved
0.7586 Intermediate Similarity NPD3620 Phase 2
0.7586 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7569 Intermediate Similarity NPD3764 Approved
0.756 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD230 Phase 1
0.7518 Intermediate Similarity NPD1283 Approved
0.7516 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6234 Discontinued
0.7466 Intermediate Similarity NPD825 Approved
0.7466 Intermediate Similarity NPD4140 Approved
0.7466 Intermediate Similarity NPD4060 Phase 1
0.7466 Intermediate Similarity NPD826 Approved
0.7451 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD3455 Phase 2
0.7429 Intermediate Similarity NPD3092 Approved
0.7427 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7415 Intermediate Similarity NPD6355 Discontinued
0.7394 Intermediate Similarity NPD7228 Approved
0.7391 Intermediate Similarity NPD3091 Approved
0.7386 Intermediate Similarity NPD7236 Approved
0.7375 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD2629 Approved
0.7347 Intermediate Similarity NPD2979 Phase 3
0.7343 Intermediate Similarity NPD3094 Phase 2
0.7333 Intermediate Similarity NPD7473 Discontinued
0.7333 Intermediate Similarity NPD5405 Approved
0.7333 Intermediate Similarity NPD5406 Approved
0.7333 Intermediate Similarity NPD5408 Approved
0.7333 Intermediate Similarity NPD5404 Approved
0.7333 Intermediate Similarity NPD2935 Discontinued
0.7329 Intermediate Similarity NPD6798 Discontinued
0.7325 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD1281 Approved
0.7303 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD4198 Discontinued
0.7296 Intermediate Similarity NPD37 Approved
0.7286 Intermediate Similarity NPD4626 Approved
0.7267 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD4965 Approved
0.7267 Intermediate Similarity NPD2799 Discontinued
0.7267 Intermediate Similarity NPD4967 Phase 2
0.7267 Intermediate Similarity NPD4966 Approved
0.7266 Intermediate Similarity NPD9545 Approved
0.726 Intermediate Similarity NPD7008 Discontinued
0.7255 Intermediate Similarity NPD3750 Approved
0.725 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD5844 Phase 1
0.7241 Intermediate Similarity NPD9494 Approved
0.7235 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD5951 Approved
0.7222 Intermediate Similarity NPD2797 Approved
0.7222 Intermediate Similarity NPD1470 Approved
0.7219 Intermediate Similarity NPD2438 Suspended
0.7214 Intermediate Similarity NPD1651 Approved
0.7214 Intermediate Similarity NPD5691 Approved
0.7211 Intermediate Similarity NPD3268 Approved
0.7206 Intermediate Similarity NPD6858 Approved
0.7206 Intermediate Similarity NPD7094 Approved
0.7194 Intermediate Similarity NPD5536 Phase 2
0.7183 Intermediate Similarity NPD1201 Approved
0.7181 Intermediate Similarity NPD555 Phase 2
0.7181 Intermediate Similarity NPD5735 Approved
0.7179 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD258 Approved
0.7172 Intermediate Similarity NPD257 Approved
0.7171 Intermediate Similarity NPD2346 Discontinued
0.7164 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD3095 Discontinued
0.7162 Intermediate Similarity NPD6233 Phase 2
0.7152 Intermediate Similarity NPD6232 Discontinued
0.7152 Intermediate Similarity NPD7239 Suspended
0.7143 Intermediate Similarity NPD7819 Suspended
0.7133 Intermediate Similarity NPD3972 Approved
0.7125 Intermediate Similarity NPD6873 Phase 2
0.7114 Intermediate Similarity NPD943 Approved
0.711 Intermediate Similarity NPD8150 Discontinued
0.7105 Intermediate Similarity NPD6100 Approved
0.7105 Intermediate Similarity NPD2531 Phase 2
0.7105 Intermediate Similarity NPD6099 Approved
0.7097 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD5585 Approved
0.7086 Intermediate Similarity NPD7097 Phase 1
0.7083 Intermediate Similarity NPD5327 Phase 3
0.7081 Intermediate Similarity NPD1934 Approved
0.707 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD7768 Phase 2
0.7051 Intermediate Similarity NPD3300 Phase 2
0.7047 Intermediate Similarity NPD259 Phase 1
0.7042 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD4059 Approved
0.7029 Intermediate Similarity NPD1241 Discontinued
0.7029 Intermediate Similarity NPD5283 Phase 1
0.7019 Intermediate Similarity NPD6677 Suspended
0.7018 Intermediate Similarity NPD7685 Pre-registration
0.7014 Intermediate Similarity NPD1608 Approved
0.7014 Intermediate Similarity NPD9269 Phase 2
0.7013 Intermediate Similarity NPD4534 Discontinued
0.7012 Intermediate Similarity NPD7075 Discontinued
0.7007 Intermediate Similarity NPD228 Approved
0.7 Intermediate Similarity NPD3226 Approved
0.6994 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6992 Remote Similarity NPD5909 Discontinued
0.6988 Remote Similarity NPD7199 Phase 2
0.6981 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6972 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6964 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6964 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6964 Remote Similarity NPD6166 Phase 2
0.6959 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6957 Remote Similarity NPD6599 Discontinued
0.6951 Remote Similarity NPD3882 Suspended
0.6948 Remote Similarity NPD5762 Approved
0.6948 Remote Similarity NPD5763 Approved
0.6947 Remote Similarity NPD3020 Approved
0.6939 Remote Similarity NPD4624 Approved
0.6939 Remote Similarity NPD2798 Approved
0.6936 Remote Similarity NPD8313 Approved
0.6936 Remote Similarity NPD8312 Approved
0.6933 Remote Similarity NPD2801 Approved
0.6933 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6933 Remote Similarity NPD7961 Discontinued
0.6933 Remote Similarity NPD1465 Phase 2
0.6933 Remote Similarity NPD4062 Phase 3
0.6929 Remote Similarity NPD7157 Approved
0.6928 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6928 Remote Similarity NPD3748 Approved
0.6923 Remote Similarity NPD1778 Approved
0.6919 Remote Similarity NPD7240 Approved
0.6918 Remote Similarity NPD1876 Approved
0.6914 Remote Similarity NPD7411 Suspended
0.6914 Remote Similarity NPD8434 Phase 2
0.6913 Remote Similarity NPD3027 Phase 3
0.6908 Remote Similarity NPD6653 Approved
0.6908 Remote Similarity NPD6353 Approved
0.6905 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6903 Remote Similarity NPD970 Clinical (unspecified phase)
0.6901 Remote Similarity NPD7074 Phase 3
0.6901 Remote Similarity NPD1894 Discontinued
0.6899 Remote Similarity NPD1511 Approved
0.6892 Remote Similarity NPD9569 Approved
0.689 Remote Similarity NPD3817 Phase 2
0.689 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6889 Remote Similarity NPD3134 Approved
0.6883 Remote Similarity NPD4476 Approved
0.6883 Remote Similarity NPD4477 Approved
0.6879 Remote Similarity NPD9493 Approved
0.6879 Remote Similarity NPD405 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6875 Remote Similarity NPD3496 Discontinued
0.6875 Remote Similarity NPD3847 Discontinued
0.6871 Remote Similarity NPD1164 Approved
0.6871 Remote Similarity NPD3266 Approved
0.6871 Remote Similarity NPD3267 Approved
0.6867 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6867 Remote Similarity NPD2313 Discontinued
0.6859 Remote Similarity NPD6674 Discontinued
0.6857 Remote Similarity NPD690 Clinical (unspecified phase)
0.6855 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6852 Remote Similarity NPD4380 Phase 2
0.6849 Remote Similarity NPD4359 Approved
0.6849 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6846 Remote Similarity NPD2614 Approved
0.6842 Remote Similarity NPD274 Approved
0.6842 Remote Similarity NPD447 Suspended
0.6842 Remote Similarity NPD275 Approved
0.6842 Remote Similarity NPD3657 Discovery
0.6842 Remote Similarity NPD7054 Approved
0.6839 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6839 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6838 Remote Similarity NPD1358 Approved
0.6835 Remote Similarity NPD7440 Discontinued
0.6835 Remote Similarity NPD5535 Approved
0.6828 Remote Similarity NPD1535 Discovery

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data